Clinical Trial Update: The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial, sponsored by Sun Yat-sen University, is evaluating whether GM-CSF can prevent oral mucositis in patients with nasopharyngeal carcinoma under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: GM-CSF | Phase 2 | Status: RECRUITING